Zydus Pharmaceuticals (USA) recalls

Zydus Pharmaceuticals (USA) has 95 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 12 Aug 2026. 35 are still ongoing. 14 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls95since 2012
Last 12 months14reported
Class I33% of total
Ongoing35latest 12 Aug 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 3 3%Class II 77 81%Class III 15 16%

By year

Ongoing zydus pharmaceuticals (usa) recalls

35 active

All zydus pharmaceuticals (usa) recalls, newest first

95 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIMirabegron Extended-Release Tablets, 25 mg recalledMirabegronZydus Pharmaceuticals (USA)Nitrosamine ImpurityNationwide
DrugCLASS IIErythromycin Tablets, USP, 250 mg recalledErythromycinZydus Pharmaceuticals (USA)Nitrosamine ImpurityNationwide
DrugCLASS IIErythromycin Tablets, USP, 500 mg recalledErythromycinZydus Pharmaceuticals (USA)Nitrosamine ImpurityNationwide
DrugCLASS IIIcosapent Ethyl Capsules recalled by Zydus Pharmaceuticals (USA)Icosapent EthylZydus Pharmaceuticals (USA)OtherNationwide
DrugCLASS IIIcosapent Ethyl capsules recalled by Zydus Pharmaceuticals (USA)Zydus Pharmaceuticals (USA)Potency & AssayNationwide
DrugCLASS IIItraZODONE Hydrochloride Tablets, USP, 100mg recalledTrazodone HydrochlorideZydus Pharmaceuticals (USA)OtherNationwide
DrugCLASS IIBromocriptine Mesylate Capsules, USP, 5 mg recalledBromocriptine MesylateZydus Pharmaceuticals (USA)Potency & AssayNationwide
DrugCLASS IIclomiPRAMINE Hydrochloride, Capsules, USP, 75 mg recalledClomipramine HydrochlorideZydus Pharmaceuticals (USA)Nitrosamine ImpurityNationwide
DrugCLASS IIclomiPRAMINE Hydrochloride, Capsules, USP, 50 mg recalledClomipramine HydrochlorideZydus Pharmaceuticals (USA)Nitrosamine ImpurityNationwide
DrugCLASS IIclomiPRAMINE Hydrochloride, Capsules, USP, 25 mg recalledClomipramine HydrochlorideZydus Pharmaceuticals (USA)Nitrosamine ImpurityNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.